Top News

Shire Proposes Combination with Baxalta

Aug 04, 2015

Shire takes its offer for an all-stock transaction to combine with Baxalta to shareholders after Baxalta declines to discuss the proposal.

Ebola Vaccine Shows 100% Efficacy in Phase III Trial

Aug 04, 2015

World on the verge of an effective Ebola Vaccine according to WHO.

FDA Approves First 3D-Printed Drug Product

Aug 03, 2015

Aprecia Pharmaceutical’s SPRITAM levetiracetam gains FDA approval for the treatment of epilepsy.

Industry News

Ebola Vaccine Shows 100% Efficacy in Phase III Trial

Aug 04, 2015

World on the verge of an effective Ebola Vaccine according to WHO.

FDA Outlines Fees for Drug Compounding Companies

Aug 03, 2015

FDA issues guidance regarding fees for drug compounding outsourcing facilities.

FDA Issues Dissolution Testing Guidance

Aug 03, 2015

FDA issues draft guidance on dissolution testing for immediate-release solid oral dosage forms.

Supplier News

Xcelience Makes Investment in Powdersize

Investment in Powdersize adds particle-size control solutions to Xcelience’s capabilities.

EMD Millipore Collaborates with celares GmbH to Offer Pegylation Services

The new service offering includes feasibility studies, process and analytical development, and scale-up from milligram to gram quantities required for pilot and subsequent commercial scale.

BioOutsource Opens New Facility in Glasgow

The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.

Bio/Pharma News

Shire Acquires Foresight Biotherapeutics for $300 Million

The acquisition strengthens Shire’s ophthalmics portfolio.

Merck Signs Licensing Deal to Use Codexis’ Protein Engineering Technology

The agreement gives Merck a non-exclusive license to use Codexis’ proprietary CodeEvolver protein engineering platform technology to develop novel enzymes for use in the manufacture of Merck’s pharmaceutical products.

Novartis Creates Biotech Spin-Off Mereo

The new biotech company, Mereo, is based in the United Kingdom, and kicks off with three mid-stage assets from Novartis.

Standards/Regulations

FDA Outlines Fees for Drug Compounding Companies

FDA issues guidance regarding fees for drug compounding outsourcing facilities.

FDA Issues Dissolution Testing Guidance

FDA issues draft guidance on dissolution testing for immediate-release solid oral dosage forms.

FDA Quality Metrics Offer Regulatory “Carrots” for Manufacturers

The broader aim of FDA's metrics initiative is to encourage quality manufacturing operations that will help avoid drug shortages.

CPhI 2015 Update

2015 CPhI Pharma Awards

The 2015 CPhI Pharma Awards honors innovation in all phases of small-molecule and large-molecule drug development.

CPhI Adds Expert Panel Members

Industry experts from Biocon, PBOA, PCI, and Pharmatech Associates join CPhI annual report for 2015.

USP Stresses Pharmacopeial Standards at CPhI China

The US Pharmacopeial Convention hosts compliance seminar at CPhI China 2015.

Drug Manufacturing

Merck Signs Licensing Deal to Use Codexis’ Protein Engineering Technology

The agreement gives Merck a non-exclusive license to use Codexis’ proprietary CodeEvolver protein engineering platform technology to develop novel enzymes for use in the manufacture of Merck’s pharmaceutical products.

FDA Approves First 3D-Printed Drug Product

Aprecia Pharmaceutical’s SPRITAM levetiracetam gains FDA approval for the treatment of epilepsy.

The Potential of Perfusion

Potential for improved product quality and cost/time savings is reviving interest in perfusion technology.

Drug Development

arGEN-X Partners with University of Bern to Develop Combination Cancer Therapies

ARGX-110-based combination therapies have demonstrated potential in treatment-resistant cancers.

Sanofi and Regeneron Form Immuno-Oncology Pact

The collaboration will focus on advancing bi-specific antibodies that target hematologic and solid cancers, either as monotherapies or in combination regimens with other immune modulating treatments.

EMA Issues Guideline on Fast Tracking Drugs for Unmet Needs

EMA’s revised guideline on the implementation of accelerated assessment is open for public consultation.

Current Issue

Beyond the Blink: Using In-Situ Gelling to Optimize Opthalmic Drug Delivery

Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.

Multimode Microplate Reader Expands Versatility

Thermo Scientific’s multimode microplate reader, the Varioskan LUX, is designed with intuitive software to allow for automatic and versatile functionality when performing microplate assays.

LED Light Source Maximizes Convenience

Anton Paar’s MCP polarimeters are now designed with a new LED light source and optional integrated air pump to clean and dry sample cells.

USP Supply Chain Safety Videos

Sponsored Videos for Bio

 

PharmTech Talk

Needle in the Haystack, or Rembrandt in the Attic? Drug Repurposing's New Strategy

Competitive pressures are driving more companies to repurpose APIs that had originally been developed for other indications and the industry has only scratched the surface of what might be possible.

FDA Quality Metrics Offer Regulatory “Carrots” for Manufacturers

The broader aim of FDA's metrics initiative is to encourage quality manufacturing operations that will help avoid drug shortages.

Are IPRs Impacting the Pharmaceutical Industry?

As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.

PharmTech Europe

25th Anniversary Issue

Experts review bio/pharma industry growth and future prospects as Pharmaceutical Technology Europe marks its 25th anniversary.

 

 

 

PharmTech Europe Archives

 

Peer-Review Research

Beyond the Blink: Using In-Situ Gelling to Optimize Opthalmic Drug Delivery

Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.

Using a Dual-Drug Resinate Complex for Taste Masking

Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.

Evaluating Disinfectant Efficacy of a Silver-Based Disinfectant

The author reports results of evaluations and concludes that a disinfectant composed of a low-concentration suspension of silver ions is completely sporicidal with only a one-minute contact time.

Editor's Picks

What’s In a Name? For Biosimilars, A Lot

Will biosimilars share a compendial identity like generic drugs do?

Designing Clean Zones

Clearly defined zones of cleanliness must be designed and maintained to prevent product contamination.

Aging Facilities: Aseptic Manufacturing Faces the Future

Aging facilities and inadequate quality systems create drug shortages. Preventing them will require harmonized regulations, and management support for continuous improvement and innovation.

PharmTech eBooks

 

Bioprocessing and Sterile Manufacturing eBook
The editors examine novel sterile and bioprocessing technologies including single-use systems, aging systems, cleanrooms, and lyophilization.  View eBook

 

More eBooks
Solid Dosage and Excipients
Analytical and Bioanalytical Testing